MedTrace Logo

Financial Toxicity in Patients With Resected Soft Tissue and Bone Sarcomas

NCT07215611 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 100

Last updated 2026-04-30

No results posted yet for this study

Summary

To learn about the financial stress patients undergoing surgery to treat orthopedic cancer experience because of the costs of cancer care, and to learn about the effects of financial stress on participants quality of life.

Conditions

  • Bone Sarcomas
  • Financial Toxicity

Interventions

OTHER

data collection

data collection from electronic health records

Sponsors & Collaborators

  • M.D. Anderson Cancer Center

    lead OTHER

Principal Investigators

  • Shalin S Patel, MD · M.D. Anderson Cancer Center

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-02
Primary Completion
2028-10-02
Completion
2030-10-02

Countries

  • United States

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT07215611 on ClinicalTrials.gov